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tion	 in	 women.	 In	 PPMS,	 a	 male	 preponderance	 was	 observed	 in	 all	 age‐groups,	
which	might	point	 to	pathophysiological	mechanisms	being	 less	 influenced	by	 sex	
hormones.
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male	ratio	 (F/M	ratio)	 in	MS	have	 increased	over	the	 last	decades,	
while age at MS onset has decreased.2	Several	etiological	factors	as‐
sociated	with	modern	lifestyle	are	considered	as	possible	reasons	for	
shifts	in	MS	prevalence,	F/M	ratio,	and	age	at	onset.2,3 Whereas the 
relapsing‐remitting	(RR)	disease	course	has	a	female	preponderance,	
the	 primary	 progressive	 MS	 (PPMS)	 phenotype	 has	 a	 slight	 male	
preponderance	 with	 approximately	 60%	 of	 patients	 being	 male.5 








changes	 in	 the	 F/M	 ratio	 throughout	 the	 last	 decades,	 and	 (c)	 to	
evaluate	sex	ratios	 in	different	MS	phenotypes.	This	may	provide	
a	better	 insight	 into	the	 impact	of	sex	hormones	on	pathophysio‐




cated	 in	 Athens	 (Greece),	 Bern	 (Switzerland),	 Bochum	 (Germany),	
and	 Peine	 (Germany).	 In	 the	 participating	 centers,	 data	 were	
gathered	 from	medical	 records	and	 from	previously	published	 ret‐
rospective	MS	studies	with	different	nonepidemiological	scopes.8,9 
The	 study	 was	 approved	 by	 the	 responsible	 local	 ethics	 commit‐







F I G U R E  1  Age	at	disease	diagnosis	(mean	±	standard	deviation	
(SD)).	Statistics:	Kruskal‐Wallis	test.	###P < 0.001.
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Age	was	used	as	a	continuous	variable	presented	as	mean	and	
standard	 deviation	 (SD),	whereas	 year	 of	 birth	was	 categorized	
for	 our	 analysis.	 Continuous	 variables	 were	 analyzed	 using	 the	
Mann‐Whitney	 test	 (MWT)	 or	 Kruskal‐Wallis	 test	 for	 compari‐





dent	 variable	 (continuous),	 which	was	 run	 separately	 for	 the	 four	
different	 disease	 courses	 (radiologically	 isolated	 syndrome	 (RIS),	
clinically	isolated	syndrome	(CIS),	RRMS,	and	PPMS).	In	the	regres‐
sion	analysis,	we	defined	significance	as	a	P‐value	<0.013	following	







nificantly	 different	 between	 MS	 phenotypes.	 Compared	 to	 all	
























of	 age	 but	 a	male	 preponderance	 (1.0:1.5)	 in	 patients	 >50	years	
was	 previously	 reported.14	 A	 decreasing	 age	 at	 diagnosis,	which	
might	contribute	to	an	increase	in	female	preponderance,	was	also	







ences	 in	 female	 preponderance	 between	CIS,	 RRMS,	 and	 PPMS	
had	not	been	investigated.	As	demonstrated	in	our	patient	cohort,	
PPMS	patients	were	older	and	had	a	slight	male	preponderance,	
which	 is	also	supported	by	other	cohort	 studies.12,19	The	 female	
preponderance	 in	 RRMS	may	 be	 owed	 to	 sex	 differences	 in	 im‐
mune	 function	 driven	 by	 hormonal	 factors,	which	 predispose	 to	
stronger	autoimmune	responses	in	women.20	On	the	contrary,	the	





encephalomyelitis,	 male	mice	 have	 a	more	 severe	Wallerian	 de‐
generation	in	the	central	nervous	system	than	females.23 Another 









Disease course Female (%) Male (%) Total Female‐to‐male ratio
RIS 36	(69%) 16	(31%) 52 2.3:1.0
CIS 106	(62%) 64	(38%) 170 1.7:1.0
RRMS 417	(67%) 208	(33%) 625 2.0:1.0
PPMS 34	(35%) 64	(65%) 98 0.5:1.0
Total 593	(63%) 352	(37%) 945 1.9:1.0
RRMS
≤58	years 412	(67%) 203	(33%) 615 2.0:1.0
>58	years 5	(50%) 5	(50%) 10 1.0:1.0
TA B L E  1  Gender	distribution	for	
different	MS	phenotypes	and	for	the	age	
cut	off	of	the	RRMS	group







diagnostic	 criteria	 used	 over	 time	 in	 patients	 included	 in	 this	 study,	
since these were subject to substantial changes over the last decades.
To	conclude,	our	data	demonstrate	a	varying	female	preponder‐
ance	 in	 different	MS	 disease	 groups.	 Furthermore,	 except	 for	 the	
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F I G U R E  3  Female‐to‐male	ratio	in	RRMS	patients	stratified	by	
year	of	birth.	Note:	Female‐to‐male	ratios	not	given	for	other	MS	
phenotypes	due	to	low	patient	numbers




OR 95% CI P‐value R2
RIS 0.99 0.94‐1.04 0.59 0.01
CIS 0.99 0.96‐1.01 0.28 0.01
RRMS 0.97 0.96‐0.99 <0.001 0.02




F I G U R E  4  Predicted	probability	of	female	sex	in	regard	to	age	
at	diagnosis.	Predicted	probabilities	were	obtained	by	respective	
logistic	regression	analysis,	which	is	presented	in	detail	in	Table	2
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